Pre-percutaneous coronary intervention sudden cardiac arrest in ST-elevation myocardial infarction: Incidence,

Guilherme Pinheiro Machado1,2, Andre Luiz Theobald1,2, Gustavo Neves de Araujo3,4

  • 1Postgraduate Program in Health Sciences: Cardiology and Cardiovascular Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Insights

Sudden cardiac arrest (SCA) before percutaneous coronary intervention (PCI) in ST-segment elevation myocardial infarction (STEMI) patients significantly increases in-hospital mortality. However, long-term survival for SCA survivors is comparable to those without SCA.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Research

Background:

  • ST-segment elevation myocardial infarction (STEMI) is a primary cause of sudden cardiac arrest (SCA).
  • Early percutaneous coronary intervention (PCI) improves survival in STEMI patients.
  • Despite advancements, SCA management outcomes remain suboptimal.

Purpose of the Study:

  • To determine the incidence of pre-PCI SCA in STEMI admissions.
  • To evaluate the outcomes associated with pre-PCI SCA.
  • To identify predictors of pre-PCI SCA in STEMI patients.

Main Methods:

  • Prospective cohort study over 11 years including 1,493 STEMI patients.
  • All patients underwent emergency coronary angiography.
  • Assessment of baseline characteristics, procedural details, reperfusion strategies, and adverse outcomes, including in-hospital and 1-year mortality.

Main Results:

  • Pre-PCI SCA occurred in 8.9% of STEMI patients (133/1,493).
  • In-hospital mortality was significantly higher in the pre-PCI SCA group (36.8% vs. 8.8%).
  • Anterior MI, cardiogenic shock, older age, and lower ejection fraction predicted in-hospital mortality; younger age and cardiogenic shock predicted pre-PCI SCA. The combination of pre-PCI SCA and cardiogenic shock amplified mortality risk.

Conclusions:

  • Pre-PCI SCA is linked to increased in-hospital mortality in STEMI patients, particularly when combined with cardiogenic shock.
  • Long-term mortality for STEMI patients who survive pre-PCI SCA is similar to those who do not experience SCA.
  • Identifying characteristics of patients at risk for pre-PCI SCA is crucial for improving STEMI management and prevention strategies.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
45
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
18
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
30
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
18
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
39
Cardiopulmonary Resuscitation III: AED Use01:23

Cardiopulmonary Resuscitation III: AED Use

Introduction to AEDAn Automated External Defibrillator (AED) is a portable medical device that analyzes the heart's rhythm and, if necessary, delivers an electrical shock to help the heart re-establish an effective rhythm during sudden cardiac arrest (SCA). SCA occurs when the heart suddenly and unexpectedly stops beating, leading to a loss of blood flow to the brain and other vital organs. In such emergencies, time is of the essence, and using an AED, combined with Cardiopulmonary...
46